ロード中...
Prevalence of mixed dyslipidemia among Australian patients undergoing lipid-modifying therapy
BACKGROUND: Few studies have assessed the prevalence of mixed dyslipidemia (MD) and the effectiveness of lipid-modifying therapy (LMT) for the treatment of abnormal levels of low-density lipoprotein cholesterol (LDL-C), triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C) in Australia...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Pulsus Group Inc
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3716499/ https://ncbi.nlm.nih.gov/pubmed/24294045 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|